Belite Bio Inc

NASDAQ: BLTE · Real-Time Price · USD
63.42
1.61 (2.60%)
At close: Aug 20, 2025, 3:59 PM
62.20
-1.92%
After-hours: Aug 20, 2025, 04:18 PM EDT

Belite Bio Inc Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-36.14M -31.63M -12.65M -9.67M
Depreciation & Amortization
449K 399K 198K 30K
Stock-Based Compensation
8.99M 3.82M 1.48M 1.53M
Other Working Capital
1.06M -2.35M -459K 640K
Other Non-Cash Items
-3.66M 4.69M 1.91M -8K
Deferred Income Tax
n/a -4.69M -1.91M n/a
Change in Working Capital
1.13M -2.43M -491K 640K
Operating Cash Flow
-29.23M -29.84M -11.46M -7.47M
Capital Expenditures
-151K -63K -394K -74K
Cash Acquisitions
n/a n/a n/a 18K
Purchase of Investments
-188.26M n/a n/a n/a
Sales Maturities Of Investments
77.84M n/a n/a n/a
Other Investing Acitivies
-35K n/a n/a n/a
Investing Cash Flow
-110.57M -63K -394K -56K
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
41.36M -1.23M -1.03M n/a
Financial Cash Flow
83.59M 75.96M 36.96M -583K
Net Cash Flow
-56.48M 46.07M 24.75M -8.27M
Free Cash Flow
-29.39M -29.9M -11.85M -7.55M